Detalles de la búsqueda
1.
The Prognostic Value of CD39 as a Marker of Tumor-Specific T Cells in Triple-Negative Breast Cancer in Asian Women.
Lab Invest;
104(3): 100303, 2024 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38103870
2.
Outcomes in Nonmetastatic Hormone Receptor-Positive HER2-Negative Pure Mucinous Breast Cancer: A Multicenter Cohort Study.
J Natl Compr Canc Netw;
: 1-9, 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38744306
3.
Early Triple-Negative Breast Cancers in a Singapore Cohort Exhibit High PIK3CA Mutation Rates Associated With Low PD-L1 Expression.
Mod Pathol;
36(4): 100056, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36788078
4.
Hypoxia-regulated carbonic anhydrase IX (CAIX) protein is an independent prognostic indicator in triple negative breast cancer.
Breast Cancer Res;
24(1): 38, 2022 06 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35659359
5.
Quantitative stain-free imaging and digital profiling of collagen structure reveal diverse survival of triple negative breast cancer patients.
Breast Cancer Res;
22(1): 42, 2020 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32375854
6.
Tertiary lymphoid structures and associated plasma cells play an important role in the biology of triple-negative breast cancers.
Breast Cancer Res Treat;
180(2): 369-377, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32034580
7.
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma.
Blood;
132(11): 1146-1158, 2018 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-30054295
8.
Grit protects medical students from burnout: a longitudinal study.
BMC Med Educ;
20(1): 266, 2020 Aug 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32787919
9.
Evaluation of phospho-histone H3 in Asian triple-negative breast cancer using multiplex immunofluorescence.
Breast Cancer Res Treat;
178(2): 295-305, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31410680
10.
PD1 blockade with pembrolizumab is highly effective in relapsed or refractory NK/T-cell lymphoma failing l-asparaginase.
Blood;
129(17): 2437-2442, 2017 04 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-28188133
11.
Higher densities of Foxp3+ regulatory T cells are associated with better prognosis in triple-negative breast cancer.
Breast Cancer Res Treat;
163(1): 21-35, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28233108
12.
A mussel-inspired double-crosslinked tissue adhesive on rat mastectomy model: seroma prevention and in vivo biocompatibility.
J Surg Res;
215: 173-182, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28688644
13.
Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer.
Breast Cancer Res Treat;
156(2): 237-47, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26960711
14.
Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival.
Histopathology;
68(5): 702-12, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26259780
15.
Role of epithelial-mesenchymal transition markers in triple-negative breast cancer.
Breast Cancer Res Treat;
152(3): 489-98, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26123543
16.
Characteristics and behaviour of screen-detected ductal carcinoma in situ of the breast: comparison with symptomatic patients.
Breast Cancer Res Treat;
152(2): 293-304, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26077641
17.
Loss of androgen receptor expression predicts early recurrence in triple-negative and basal-like breast cancer.
Mod Pathol;
27(3): 352-60, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23929266
18.
Lysine-Specific Demethylase 1 (LSD1)-Mediated Epigenetic Modification of Immunogenicity and Immunomodulatory Effects in Breast Cancers.
Curr Oncol;
30(2): 2127-2143, 2023 02 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36826125
19.
Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer.
Histopathology;
61(4): 652-9, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22759273
20.
Epithelial-mesenchymal transition and cancer stem cell interactions in breast phyllodes tumours: immunohistochemical evaluation of EZH2, EZR, HMGA2, CD24 and CD44 in correlation with outcome analysis.
J Clin Pathol;
75(5): 316-323, 2022 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-33627375